Royal Bank of Canada’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$284K Sell
19,541
-12,892
-40% -$124K ﹤0.01% 4744
2026
Q1
$240K Buy
32,433
+14,402
+80% +$152K ﹤0.01% 4602
2025
Q4
$212K Sell
18,031
-3,339
-16% -$36K ﹤0.01% 4712
2025
Q3
$165K Sell
21,370
-41,129
-66% -$288K ﹤0.01% 5209
2025
Q2
$457K Buy
62,499
+6,473
+12% +$52.2K ﹤0.01% 4540
2025
Q1
$532K Buy
56,026
+18,966
+51% +$237K ﹤0.01% 3959
2024
Q4
$610K Sell
37,060
-2,000
-5% -$31.1K ﹤0.01% 3922
2024
Q3
$576K Buy
39,060
+7,182
+23% +$112K ﹤0.01% 3982
2024
Q2
$442K Buy
31,878
+15,131
+90% +$215K ﹤0.01% 4117
2024
Q1
$264K Sell
16,747
-30,258
-64% -$467K ﹤0.01% 4457
2023
Q4
$760K Buy
47,005
+21,448
+84% +$351K ﹤0.01% 3887
2023
Q3
$315K Buy
25,557
+1,283
+5% +$19.1K ﹤0.01% 4407
2023
Q2
$389K Buy
24,274
+7,186
+42% +$118K ﹤0.01% 4144
2023
Q1
$297K Sell
17,088
-17,811
-51% -$254K ﹤0.01% 4298
2022
Q4
$322K Buy
34,899
+17,165
+97% +$160K ﹤0.01% 4478
2022
Q3
$152K Sell
17,734
-2,065
-10% -$20.5K ﹤0.01% 4980
2022
Q2
$162K Sell
19,799
-21,211
-52% -$203K ﹤0.01% 4964
2022
Q1
$500K Buy
41,010
+10,781
+36% +$227K ﹤0.01% 4275
2021
Q4
$1.03M Buy
30,229
+12,728
+73% +$498K ﹤0.01% 3776
2021
Q3
$844K Sell
17,501
-39,176
-69% -$1.81M ﹤0.01% 3875
2021
Q2
$2.56M Sell
56,677
-19,656
-26% -$871K ﹤0.01% 2851
2021
Q1
$3.68M Sell
76,333
-63,587
-45% -$3.31M ﹤0.01% 2472
2020
Q4
$7.53M Buy
139,920
+38,136
+37% +$1.72M ﹤0.01% 1916
2020
Q3
$3.75M Sell
101,784
-38,706
-28% -$1.44M ﹤0.01% 2198
2020
Q2
$4.35M Buy
140,490
+128,489
+1,071% +$3.56M ﹤0.01% 2036
2020
Q1
$332K Sell
12,001
-4,120
-26% -$123K ﹤0.01% 3958
2019
Q4
$471K Buy
16,121
+10,189
+172% +$243K ﹤0.01% 4033
2019
Q3
$113K Sell
5,932
-4,533
-43% -$106K ﹤0.01% 4740
2019
Q2
$230K Buy
10,465
+5,874
+128% +$129K ﹤0.01% 4392
2019
Q1
$94K Buy
4,591
+2,228
+94% +$38.7K ﹤0.01% 4810
2018
Q4
$29K Sell
2,363
-333
-12% -$4.96K ﹤0.01% 5400
2018
Q3
$41K Buy
2,696
+2,604
+2,830% +$36K ﹤0.01% 5331
2018
Q2
$1K Sell
92
-750
-89% -$8.25K ﹤0.01% 6371
2018
Q1
$7K Sell
842
-38
-4% -$308 ﹤0.01% 5837
2017
Q4
$7K Sell
880
-4,651
-84% -$42.9K ﹤0.01% 5986
2017
Q3
$61K Buy
5,531
+5,339
+2,781% +$52K ﹤0.01% 5308
2017
Q2
$2K Sell
192
-1,844
-91% -$14.6K ﹤0.01% 6277
2017
Q1
$16K Sell
2,036
-1,814
-47% -$14.8K ﹤0.01% 5739
2016
Q4
$33K Buy
3,850
+3,813
+10,305% +$32.7K ﹤0.01% 5491
2016
Q3
$0 Sell
37
-250
-87% -$2.1K ﹤0.01% 6516
2016
Q2
$2K Buy
+287
New +$2.3K ﹤0.01% 6147
2015
Q4
Sell
-2,226
Closed -$13K 6765
2015
Q3
$13K Sell
2,226
-10,441
-82% -$64.6K ﹤0.01% 5767
2015
Q2
$68K Buy
12,667
+2,667
+27% +$13.8K ﹤0.01% 5053
2015
Q1
$47K Hold
10,000
﹤0.01% 4992
2014
Q4
$42K Hold
10,000
﹤0.01% 5124
2014
Q3
$52K Hold
10,000
﹤0.01% 4928
2014
Q2
$33K Buy
+10,000
New +$33.2K ﹤0.01% 5029
2013
Q4
Sell
-1,082
Closed -$3K 6065
2013
Q3
$3K Buy
+1,082
New +$3.05K ﹤0.01% 5764

Other funds holding NEO

Royal Bank of Canada's NEO Position: Q2 2026 in Review

Royal Bank of Canada reduced its NeoGenomics (NEO) stake by 40% in Q2 2026, selling an estimated $124K and leaving 19,541 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #4744.

Royal Bank of Canada first reported a position in NEO in Q3 2013 and has held it in 48 quarters since. The position peaked at $7.53M in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Royal Bank of Canada held 19,541 shares of NeoGenomics worth $284K as of Q2 2026.
  • Royal Bank of Canada sold 12,892 NeoGenomics shares in Q2 2026, an estimated $124K.
  • NeoGenomics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #4744 holding.
  • Royal Bank of Canada first reported a position in NeoGenomics in Q3 2013 and has held it in 48 quarters since.
  • Royal Bank of Canada's NeoGenomics position peaked at $7.53M in Q4 2020.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.